Aldo-keto reductase 7A5 (AKR7A5) attenuates oxidative stress and reactive aldehyde toxicity in V79-4 cells

Toxicology in Vitro

Volumn 28, Issue 4, 2014, Pages 707-714

  Li, Dan ^a,b   Ellis, Elizabeth M ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Aldehydes; Aldoketo reductase 7A5; Hydrogen peroxide; Menadione; Oxidative stress

Indexed keywords

ALDEHYDE; ALDEHYDE DERIVATIVE; ALDO KETO REDUCTASE; ALDO KETO REDUCTASE 7A5; GLUTATHIONE; HEXANAL; HYDROGEN PEROXIDE; MENADIONE; METHYLGLYOXAL; OXIDOREDUCTASE; REACTIVE ALDEHYDE; REACTIVE OXYGEN METABOLITE; TRANS 2 NONENAL; UNCLASSIFIED DRUG; ALDEHYDE REDUCTASE; BENZALDEHYDE; BENZALDEHYDE DERIVATIVE; CARBONYL REDUCTASE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DAMAGE; CELL LINE; CELL PROTECTION; CHINESE HAMSTER; CONTROLLED STUDY; CYTOTOXICITY; LUNG FIBROBLAST; MAMMAL CELL; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; TRANSGENICS; V79 4 CELL; ANIMAL; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HAMSTER; METABOLISM; PHYSIOLOGY;

ALDEHYDE REDUCTASE; ANIMALS; BENZALDEHYDES; CELL LINE; CELL SURVIVAL; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GLUTATHIONE; HYDROGEN PEROXIDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; VITAMIN K 3;

EID: 84896274841     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2014.02.010     Document Type: Article

References (45)

1. Ahmed M.M., Wang T., Luo Y., Ye S., Wu Q., Guo Z., Roebuck B.D., Sutter T.R., Yang J.Y. Aldo-keto reductase-7A protects liver cells and tissues from acetaminophen-induced oxidative stress and hepatotoxicity. Hepatology 2011, 54:1322-1332.
2. Amin R.P., Witz G. DNA-protein crosslink and DNA strand break formation in HL-60 cells treated with trans, trans-muconaldehyde, hydroquinone and their mixtures. Int. J. Toxicol. 2001, 20:69-80.
3. Ariyoshi-Kishino K., Hashimoto K., Amano O., Saitoh J., Kochi M., Sakagami H. Tumor-specific cytotoxicity and type of cell death induced by benzaldehyde. Anticancer Res. 2010, 30:5069-5076.
4. Barski O.A., Tipparaju S.M., Bhatnagar A. The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. Drug Metab. Rev. 2008, 40:553-624.
5. Bodreddigari S., Jones L.K., Egner P.A., Groopman J.D., Sutter C.H., Roebuck B.D., Guengerich F.P., Kensler T.W., Sutter T.R. Protection against aflatoxin B1-induced cytotoxicity by expression of the cloned aflatoxin B1-aldehyde reductases rat AKR7A1 and human AKR7A3. Chem. Res. Toxicol. 2008, 21:1134-1142.
6. Brooks P.J., Theruvathu J.A. DNA adducts from acetaldehyde: implications for alcohol-related carcinogenesis. Alcohol 2005, 35:187-193.
7. DeAtley S.M., Aksenov M.Y., Aksenov M.V., Harris B., Hadley R., Carney J.M., Butterfield D.A. Antioxidants protect against reactive oxygen species associated with adriamycin-treated cardiomyocytes. Cancer Lett. 1999, 136:41-46.
8. Ellis E.M. Reactive carbonyls and oxidative stress: potential for therapeutic intervention. Pharmacol. Ther. 2007, 115:13-24.
9. Ellis E.M., Hayes J.D. Substrate-specificity of an aflatoxin-metabolizing aldehyde reductase. Biochem. J. 1995, 312:535-541.
10. Ellis E.M., Judah D.J., Neal G.E., Hayes J.D. An ethoxyquin-inducible aldehyde reductase from rat liver that metabolises aflatoxin B1 defines a subfammily of aldo-keto reductases. Proc. Natl. Acad. Sci. USA 1993, 90:10350-10354.
11. Endo S., Matsunaga T., Mamiya H., Hara A., Kitade Y., Tajima K., El-Kabbani O. Characterization of a rat NADPH-dependent aldo-keto reductase (AKR1B13) induced by oxidative stress. Chem. Biol. Interact. 2009, 178:151-157.
12. Engle M., Singh S., Czernik P.J., Gaddy D., Montague D.C., Ceci J.D., Yang Y., Awasthi S., Awasthi Y.C., Zimniak P. Physiological role of mGSTA4-4, a glutathione S-transferase metabolizing 4-hydroxynonenal: generation and analysis of mGsta4 null mouse. Toxicol. Appl. Pharmacol. 2004, 194:296-308.
13. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 1991, 11:81-128.
14. Fetoui H., Gdoura R. Synthetic pyrethroid increases lipid and protein oxidation and induces glutathione depletion in the cerebellum of adult rats: ameliorative effect of vitamin C. Hum. Exp. Toxicol 2012.
15. Gallagher E.P., Huisden C.M., Gardner J.L. Transfection of HepG2 cells with hGSTA4 provides protection against 4-hydroxynonenal-mediated oxidative injury. Toxicol. In Vitro 2007, 21:1365-1372.
16. Gardner R., Kazi S., Ellis E. Detoxication of the environmental pollutant acrolein by a rat liver aldo-keto reductase. Toxicol. Lett. 2004, 148:65-72.
17. Groeger G., Quiney C., Cotter T.G. Hydrogen peroxide as a cell-survival signaling molecule. Antioxid. Redox Signal. 2009, 11:2655-2671.
18. Hinshelwood A., McGarvie G., Ellis E. Characterisation of a novel mouse liver aldo-keto reductase AKR7A5. FEBS Lett. 2002, 523:213-218.
19. Hinshelwood A., McGarvie G., Ellis E.M. Substrate specificity of mouse aldo-keto reductase AKR7A5. Chem. Biol. Interact. 2003, 143-144:263-269.
20. Hissin P.J., Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 1976, 74:214-226.
21. Ishino K., Wakita C., Shibata T., Toyokuni S., Machida S., Matsuda S., Matsuda T., Uchida K. Lipid peroxidation generates body odor component trans-2-nonenal covalently bound to protein in vivo. J. Biol. Chem. 2010, 285:15302-15313.
22. Ireland L.S., Harrison D.J., Neal G.E., Hayes J.D. Molecular cloning, expression and catalytic activity of a human AKR7 member of the aldo-keto reductase superfamily: evidence that the major 2-carboxybenzaldehyde reductase from human liver is a homologue of rat aflatoxin B1-aldehyde reductase. Biochem. J. 1998, 332(Pt 1):21-34.
23. Jez J., Penning T. The aldo-keto reductase superfamily: an update. Chemico-biol. Interact. 2001, 130-132:499-525.
24. Jin Y., Penning T.M. Aldo-keto reductases and bioactivation/detoxication. Annu. Rev. Pharmacol. Toxicol. 2007, 47:263-292.
25. Jung K.A., Choi B.H., Nam C.W., Song M., Kim S.T., Lee J.Y., Kwak M.K. Identification of aldo-keto reductases as NRF2-target marker genes in human cells. Toxicol. Lett. 2013, 218:39-49.
26. Kanno T., Nakamura K., Ikai H., Kikuchi K., Sasaki K., Niwano Y. Literature review of the role of hydroxyl radicals in chemically-induced mutagenicity and carcinogenicity for the risk assessment of a disinfection system utilizing photolysis of hydrogen peroxide. J. Clin. Biochem. Nutr. 2012, 51:9-14.
27. Kelly V.P., Sherratt P.J., Crouch D.H., Hayes J.D. Novel homodimeric and heterodimeric rat gamma-hydroxybutyrate synthases that associate with the Golgi apparatus define a distinct subclass of aldo-keto reductase 7 family proteins. Biochem. J. 2002, 366:847-861.
28. Knight L.P., Primiano T., Groopman J.D., Kensler T.W., Sutter T.R. cDNA cloning, expression and activity of a second human aflatoxin B1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3. Carcinogenesis 1999, 20:1215-1223.
29. Li D., Ellis E.M. Inducible protection of human astrocytoma 1321N1 cells against hydrogen peroxide and aldehyde toxicity by 7-hydroxycoumarin is associated with the upregulation of aldo-keto reductases. Neurotoxicology 2012, 33:1368-1374.
30. Li D., Hinshelwood A., Gardner R., McGarvie G., Ellis E.M. Mouse aldo-keto reductase AKR7A5 protects V79 cells against 4-hydroxynonenal-induced apoptosis. Toxicology 2006, 226:172-180.
31. Li D., Ferrari M., Ellis E.M. Human aldo--keto reductase AKR7A2 protects against the cytotoxicity and mutagenicity of reactive aldehydes and lowers intracellular reactive oxygen species in hamster V79-4 cells. Chem. Biol. Interact. 2012, 195:25-34.
32. Lyon R.C., Li D., McGarvie G., Ellis E.M. Aldo-keto reductases mediate constitutive and inducible protection against aldehyde toxicity in human neuroblastoma SH-SY5Y cells. Neurochem. Int. 2013, 62:113-121.
33. Marchitti S.A., Brocker C., Orlicky D.J., Vasiliou V. Molecular characterization, expression analysis, and role of ALDH3B1 in the cellular protection against oxidative stress. Free Radic. Biol. Med. 2010, 49:1432-1443.
34. Mindnich R.D., Penning T.M. Aldo-keto reductase (AKR) superfamily: genomics and annotation. Hum. Genomics 2009, 3:362-370.
35. Muller K., Hardwick S.J., Marchant C.E., Law N.S., Waeg G., Esterbauer H., Carpenter K.L., Mitchinson M.J. Cytotoxic and chemotactic potencies of several aldehydic components of oxidised low density lipoprotein for human monocyte-macrophages. FEBS Lett. 1996, 388:165-168.
36. Mytilineou C., Kramer B.C., Yabut J.A. Glutathione depletion and oxidative stress. Parkinsonism Relat. Disord. 2002, 8:385-387.
37. Roebuck B.D., Johnson D.N., Sutter C.H., Egner P.A., Scholl P.F., Friesen M.D., Baumgartner K.J., Ware N.M., Bodreddigari S., Groopman J.D., Kensler T.W., Sutter T.R. Transgenic expression of aflatoxin aldehyde reductase (AKR7A1) modulates aflatoxin B1 metabolism but not hepatic carcinogenesis in the rat. Toxicol. Sci. 2009, 109:41-49.
38. Schaur R.J. Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol. Aspects Med. 2003, 24:149-159.
39. Shiraishi K., Naito K. Effects of 4-hydroxy-2-nonenal, a marker of oxidative stress, on spermatogenesis and expression of p53 protein in male infertility. J. Urol. 2007, 178:1012-1017. discussion 1017.
40. Sultana R., Perluigi M., Allan Butterfield D. Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain. Free Radic. Biol. Med 2012.
41. Svedberg U.R., Hogberg H.E., Hogberg J., Galle B. Emission of hexanal and carbon monoxide from storage of wood pellets, a potential occupational and domestic health hazard. Ann. Occup. Hyg. 2004, 48:339-349.
42. Veal E., Day A. Hydrogen peroxide as a signaling molecule. Antioxid. Redox Signal. 2011, 15:147-151.
43. Wang H., Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med. 1999, 27:612-616.
44. Williams T.I., Lynn B.C., Markesbery W.R., Lovell M.A. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer's disease. Neurobiol. Aging 2006, 27:1094-1099.
45. Witz G., Gad S.C., Tice R.R., Oshiro Y., Piper C.E., Goldstein B.D. Genetic toxicity of the benzene metabolite trans, trans-muconaldehyde in mammalian and bacterial cells. Mutat. Res. 1990, 240:295-306.